WeVote
Log In

Bill

Bill

A 6645

Ties the cost of living adjustment for pharmaceutical insurance coverage to the consumer price index

2025 Regular Session Introduced by Sam Pirozzolo

Bill A 6645 links pharmaceutical insurance cost adjustments to the Consumer Price Index, helping consumers manage rising medication costs and ensuring affordability.

REFERRED TO AGING
0
WeVote Research Nonpartisan
Bill Summary · A 6645

Summary of Bill A 6645

Bill Information

  • Bill Number: A 6645
  • Title: Ties the cost of living adjustment for pharmaceutical insurance coverage to the consumer price index
  • Status: Referred to Aging
  • Introduced: March 06, 2025
  • Classification: Bill

Purpose and Intent

Bill A 6645 aims to ensure that the cost of living adjustments (COLA) for pharmaceutical insurance coverage are directly linked to the Consumer Price Index (CPI). This connection is intended to provide a more accurate reflection of inflation and the rising costs of pharmaceuticals, thereby helping to maintain the affordability of prescription medications for insured individuals.

Key Provisions

  • Cost of Living Adjustment: The bill mandates that any adjustments to pharmaceutical insurance coverage costs must be calculated based on changes in the Consumer Price Index. This means that as the cost of living increases, so too will the adjustments made to pharmaceutical insurance coverage.
  • Implementation Timeline: While the bill has been introduced, specific implementation dates or timelines for the adjustments have not been detailed in the current version.

Who Would Be Affected

  • Consumers: Individuals with pharmaceutical insurance coverage would benefit from more predictable and potentially more equitable adjustments to their insurance costs, aligning them with real-world inflation rates.
  • Insurance Providers: Pharmaceutical insurance companies may need to adjust their pricing models and policies to comply with the new COLA requirements.
  • Healthcare System: The bill could impact overall healthcare costs and accessibility, as it aims to alleviate some financial burdens associated with rising medication prices.

Procedural Aspects

  • Current Status: As of March 06, 2025, the bill has been referred to the Aging committee for further consideration. This referral indicates that the bill will undergo review and discussion before any further legislative action is taken.

Conclusion

Bill A 6645 seeks to create a more responsive and fair system for adjusting pharmaceutical insurance costs in line with inflation. By tying these adjustments to the Consumer Price Index, the bill aims to protect consumers from the financial strain of rising medication costs, ensuring that insurance coverage remains viable and effective. Further discussions and evaluations in the Aging committee will determine the bill's future trajectory.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.